Welcome To The 3SBio Inc HUB China Securities
For 2008, the Company achieved 35% yoy revenue growth to $35.7 million.
Fast Facts
Name Symbol Exchange
3SBio Inc SSRX NASDAQ
Shares Outstanding Financials Industry
21.7M View Filings Tech & Medical
Transfer Agent Broker Fact Sheet Website
Stock Transfer Corporation Fact Sheet http://bbs.3sbio.com/en
Recent Updates
3SBio Inc RSS Feed
Press Release - Mar 10, 10 03:25AM
3SBio Announces Changes to its Board of Directors
Press Release - Feb 11, 10 08:00PM
3SBio and Ascentage Pharma Form Strategic Alliance to Research
Press Release - Feb 11, 10 08:00PM
3SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial
Press Release - Feb 08, 10 06:04AM
3SBio and Panacor Bioscience Enter Collaboration and License Agreement
Press Release - Jan 26, 10 12:19AM
3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results
Top Rated Messages

Sorry, no rated messages found

See more top rated messages
Most Recent Messages
Icon_agoracom 3SBio Announces Changes to its Board of Directors
ChinaSecurities
Mar 10, 10 03:25AM
Icon_agoracom 3SBio and Ascentage Pharma Form Strategic Alliance to Research
ChinaSecurities
Feb 11, 10 08:00PM
Icon_agoracom 3SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial
ChinaSecurities
Feb 11, 10 08:00PM
Icon_agoracom 3SBio and Panacor Bioscience Enter Collaboration and License Agreement
ChinaSecurities
Feb 08, 10 06:04AM
Icon_agoracom 3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results
ChinaSecurities
Jan 26, 10 12:19AM
Go to Full Discussion Forum
Subscribe to Rss Feed
Executive Address
Ssrx-small
3SBio Inc
Welcome to Chinasecurities.com
March 08, 2009

View Broadcast

Stock Quote
Hub Leaders
Ssrx-small
SSRX-IR